UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A

Stem cell reports, 2018-12, Vol.11 (6), p.1391-1406

2018

Volltextzugriff (PDF)

The case for wider use of recombinant factor VIII concentrates

Critical reviews in oncology/hematology, 2012-07, Vol.83 (1), p.11-20

2012

Volltextzugriff (PDF)

Identification of the Profile of the Patients with Hemophilia B Eligible for Treatment with Nonacog Alfa Once-Weekly

Reports (MDPI), 2020-03, Vol.3 (1), p.3

2020

Volltextzugriff (PDF)

A Novel Platform for Immune Tolerance Induction in Hemophilia A Mice

Molecular therapy, 2017-08, Vol.25 (8), p.1815-1830

2017

Volltextzugriff (PDF)

Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A

Blood, 2013-09, Vol.122 (11), p.1954-1962

2013

Volltextzugriff (PDF)

A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease

Blood transfusion = Trasfusione del sangue, 2019-09, Vol.17 (5), p.391-398

2019

Volltextzugriff (PDF)

Paroxysmal Nocturnal Hemoglobinuria With Budd-Chiari Syndrome Treated With Complement Inhibitor Eculizumab; A Case Report

Blood, 2013-11, Vol.122 (21), p.4800-4800

2013

Volltextzugriff (PDF)

Pain assessment and management in haemophilia: A survey among Italian patients and specialist physicians

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-09, Vol.24 (5), p.766-773

2018

Volltextzugriff (PDF)

The incidence and treatment of bleeding episodes in non-severe haemophilia A patients with inhibitors

Thrombosis and haemostasis, 2016-03, Vol.115 (3), p.543-550

2016

Volltextzugriff (PDF)

Long-Term Prophylaxis in Patients with Von Willebrand Disease and Recurrent Bleeding in Italy

Blood, 2014-12, Vol.124 (21), p.5056-5056

2014

Volltextzugriff (PDF)

Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study)

Lupus, 2016-04, Vol.25 (5), p.479-485

2016

Volltextzugriff (PDF)

Emerging issues on comprehensive hemophilia care: preventing, identifying, and monitoring age-related comorbidities

Seminars in thrombosis and hemostasis, 2013-10, Vol.39 (7), p.794-802

2013

Volltextzugriff (PDF)

179. Correcting the Bleeding Phenotype in Hemophilia Ausing Lentivirally FVIII-Corrected Endothelial Cells Differentiated from Hemophilic Induced Pluripotent Stem Cell (iPSC)

Molecular therapy, 2015-05, Vol.23, p.S71-S72

2015

Volltextzugriff (PDF)

Physical activity improved by adherence to prophylaxis in an Italian population of children, adolescents and adults with severe haemophilia A: the SHAPE Study

Blood transfusion = Trasfusione del sangue, 2020-03, Vol.18 (2), p.152-158

2020

Volltextzugriff (PDF)

Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high‐responding inhibitors

Journal of thrombosis and haemostasis, 2009-11, Vol.7 (11), p.1809-1815

2009

Volltextzugriff (PDF)

Edoxaban in Atrial Fibrillation and Venous Thromboembolism—Ten Key Questions and Answers: A Practical Guide

Advances in therapy, 2017-03, Vol.34 (3), p.620-637

2017

Volltextzugriff (PDF)

Cancers in Patients with von Willebrand Disease: A Survey from the Italian Association of Haemophilia Centres

Seminars in thrombosis and hemostasis, 2016-02, Vol.42 (1), p.36-41

2016

Volltextzugriff (PDF)

Current challenges in the diagnosis and management of patients with inherited von Willebrand's disease in Italy: an Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxis

Blood transfusion = Trasfusione del sangue, 2018-07, Vol.16 (4), p.371-381

2018

Volltextzugriff (PDF)

Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy

Blood transfusion = Trasfusione del sangue, 2014-10, Vol.12 (4), p.575-598

2014

Volltextzugriff (PDF)

retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs

Annals of hematology, 2010-07, Vol.89 (7), p.691-699

2010

Volltextzugriff (PDF)

Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management

Blood transfusion = Trasfusione del sangue, 2015-07, Vol.13 (3), p.498-513

2015

Volltextzugriff (PDF)

Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-01, Vol.18 (1), p.39-45

2012

Volltextzugriff (PDF)

Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind study

Thrombosis and haemostasis, 2012-11, Vol.108 (5), p.913-922

2012

Volltextzugriff (PDF)

Thrombotic recurrences and bleeding events in APS vascular patients: A review from the literature and a comparison with the APS Piedmont Cohort

Autoimmunity reviews, 2013-06, Vol.12 (8), p.826-831

2013

Volltextzugriff (PDF)

Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile

Lupus, 2012-06, Vol.21 (7), p.806-809

2012

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A

The case for wider use of recombinant factor VIII concentrates

Identification of the Profile of the Patients with Hemophilia B Eligible for Treatment with Nonacog Alfa Once-Weekly

A Novel Platform for Immune Tolerance Induction in Hemophilia A Mice

Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A

A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease

Paroxysmal Nocturnal Hemoglobinuria With Budd-Chiari Syndrome Treated With Complement Inhibitor Eculizumab; A Case Report

Pain assessment and management in haemophilia: A survey among Italian patients and specialist physicians

The incidence and treatment of bleeding episodes in non-severe haemophilia A patients with inhibitors

Long-Term Prophylaxis in Patients with Von Willebrand Disease and Recurrent Bleeding in Italy

Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study)

Emerging issues on comprehensive hemophilia care: preventing, identifying, and monitoring age-related comorbidities

179. Correcting the Bleeding Phenotype in Hemophilia Ausing Lentivirally FVIII-Corrected Endothelial Cells Differentiated from Hemophilic Induced Pluripotent Stem Cell (iPSC)

Physical activity improved by adherence to prophylaxis in an Italian population of children, adolescents and adults with severe haemophilia A: the SHAPE Study

Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high‐responding inhibitors

Edoxaban in Atrial Fibrillation and Venous Thromboembolism—Ten Key Questions and Answers: A Practical Guide

Cancers in Patients with von Willebrand Disease: A Survey from the Italian Association of Haemophilia Centres

Current challenges in the diagnosis and management of patients with inherited von Willebrand's disease in Italy: an Expert Meeting Report on the diagnosis and surgical and secondary long-term prophylaxis

Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy

retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs

Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management

Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors

Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind study

Thrombotic recurrences and bleeding events in APS vascular patients: A review from the literature and a comparison with the APS Piedmont Cohort

Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile

Suchergebnisse filtern